Reflecting on 2024, Cardillo emphasized the strong performance of U.S. equities, with the S&P 500 and Nasdaq hitting record highs. Nonetheless, he cautioned that markets are nearing "perfect pricing," ...
Through a series of strategic acquisitions,CR Sanjiu successfully expanded into antifungal, antitumor and anti-infection treatments.In 2023, CR Sanjiu achieved revenues of 24.74 billion yuan,with 39 ...